A new type of research into curing retinal damage could also lead to new cancer treatments, experts involved with the study claim.
Dr Richard Lang, senior investigator on the study and director of the Visual Systems Group in the Division of Ophthalmology at Cincinnati Children"s Hospital Medical Center, said the key lies in modulating a certain pathway involving blood cells in the retina.
"We show in the setting of retina that myeloid cells use this pathway to direct vascular traffic. We think modulation of this pathway might become a promising therapeutic option," he explained.
According to the expert, the research presents "a number" of new research opportunities to test its influence on retinal diseases that are often associated with abnormal blood vessel development and in the formation of tumours, which could lead to effective cancer treatments.
Also recently, researchers from the University of Wisconsin-Madison, the University of California and the WiCell Research Institute discovered that the process of correcting a genetic defect does not substantially increase the risk of pluripotent stem cells turning cancerous.
by Alexa Kaczka